Altamira Therapeutics Ltd. Gains 180.28%
Fri, Nov 17, 2023 at 07:49 PM
Altamira Therapeutics Ltd. (CYTO:NASDAQ) shot up at $0.28, a gain of 180.3%. On Fri, Nov 17, 2023, CYTO:NASDAQ touched a New 2-Week High of $0.28. The stock got featured on our News Catalysts scanner on Fri, Nov 10, 2023 at 10:36 AM in the 'PRIVATE PLACEMENT' category. From Mon, Nov 06, 2023, the stock recorded 22.22% Up Days and 10.00% Green Days
The stock spiked on Fri, Nov 17, 2023 at $0.48 with a volume of 323M+.
About Altamira Therapeutics Ltd. (CYTO:NASDAQ)
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders.
Top 10 Gainers:
- Comera Life Sciences Holdings Inc. (CMRA:NASDAQ), 900%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 180.28%
- Wang & Lee Group Inc. (WLGS:NASDAQ), 95.85%
- Syntec Optics Holdings Inc Cl A (OPTX:NASDAQ), 73.98%
- La Rosa Holdings Corp. (LRHC:NASDAQ), 55.24%
- Fortress Biotech, Inc. (FBIO:NASDAQ), 46.15%
- Zapp Electric Vehicles Group Limited (ZAPP:NASDAQ), 45.56%
- Local Bounti Corporation (LOCL:NYSE), 41.22%
- Safe and Green Development Corporation (SGD:NASDAQ), 38.94%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 38.45%